<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27009683</article-id>
<article-id pub-id-type="pmc">4983264</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2016.02.008</article-id>
<article-id pub-id-type="manuscript">NIHMS760041</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sumoylation of FOXP2 regulates motor function and vocal communication through Purkinje cell development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Usui</surname>
<given-names>Noriyoshi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Co</surname>
<given-names>Marissa</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harper</surname>
<given-names>Matthew</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rieger</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dougherty</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Konopka</surname>
<given-names>Genevieve</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390-911, USA</aff>
<aff id="A2"><label>2</label>Department of Genetics and Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Genevieve Konopka, Ph.D., Department of Neuroscience, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., ND4.300, Dallas, TX 75390-9111, USA, TEL: 214-648-5135, FAX: 214-648-1801, <email>Genevieve.Konopka@utsouthwestern.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>81</volume>
<issue>3</issue>
<fpage>220</fpage>
<lpage>230</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2016.02.008-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P2">Mutations in the gene encoding the transcription factor forkhead box P2, <italic>FOXP2</italic>, result in brain developmental abnormalities including reduced gray matter in both human patients and rodent models, and speech and language deficits. However, neither the region-specific function of FOXP2 in the brain, in particular the cerebellum, nor the effects of any post-translational modifications of FOXP2 in the brain and disorders have been explored.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">We characterized sumoylation of FOXP2 biochemically, and analyzed the region-specific function and sumoylation of FOXP2 in the developing mouse cerebellum. Using <italic>in utero</italic> electroporation to manipulate the sumoylation-state of Foxp2 as well as Foxp2 expression levels in Purkinje cells (PCs) of the cerebellum <italic>in vivo</italic>, we reduced Foxp2 expression approximately 40% in the mouse cerebellum. Such a reduction approximates the haploinsufficiency observed in human patients who demonstrate speech and language impairments.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">We identified sumoylation of FOXP2 at K674 (K673 in mouse) in the cerebellum of neonates. <italic>In vitro</italic> co-immunoprecipitation and <italic>in vivo</italic> colocalization experiments suggest that PIAS3 acts as the SUMO E3 ligase for FOXP2 sumoylation. This sumoylation modifies transcriptional regulation by FOXP2. We demonstrate that Foxp2 sumoylation is required for regulation of cerebellar motor function and vocal communication, likely through dendritic outgrowth and arborization of PCs in the mouse cerebellum.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">Sumoylation of Foxp2 in neonatal mouse cerebellum regulates PC development as well as motor functions and vocal communication, demonstrating evidence for sumoylation in regulating mammalian behaviors.</p>
</sec>
</abstract>
<kwd-group>
<kwd>FOXP2</kwd>
<kwd>Purkinje cells</kwd>
<kwd>cerebellum</kwd>
<kwd>sumoylation</kwd>
<kwd>vocal communication</kwd>
<kwd>motor function</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>